CLINICAL_TRIALS
research
· 2024-06-13
Clinical Trial Update: To Evaluate the Effect of MCS® in Prostate Cancer Prevention [Phase 2]
Summary
Phase 2 clinical trial update evaluating MCS® for prostate cancer prevention; the study is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Health Ever Bio-Tech Co., Ltd. | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING